Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Sunlands (STG) Q1 2025 Earnings Call Transcript
Motley Fool Transcribing
|
May 22, 2025
Why Barnes & Noble Education Stock Was a Raging Success This Week
Eric Volkman
|
Jul 7, 2023
The company appears to have found a very satisfied customer base for one of its offerings.
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
James Halley
|
Apr 25, 2023
The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.
Is Arrowhead Pharmaceuticals a Buy Now?
Cory Renauer
|
Apr 16, 2023
The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
George Budwell
|
Apr 4, 2023
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.
Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 5, 2022
ARWR earnings call for the period ending June 30, 2022.
Arrowhead Pharmaceuticals (ARWR) Q2 2022 Earnings Call Transcript
Motley Fool Transcribing
|
May 11, 2022
ARWR earnings call for the period ending March 31, 2022.
Arrowhead Pharmaceuticals (ARWR) Q1 2022 Earnings Call Transcript
Motley Fool Transcribing
|
Feb 3, 2022
ARWR earnings call for the period ending December 31, 2021.
3 Biotech Stocks That Could Go Parabolic in 2022
George Budwell
|
Jan 18, 2022
Arrowhead Pharmaceuticals, Madrigal Pharmaceuticals, and Viking Therapeutics could be big winners this year.
Barnes & Noble Education, inc (BNED) Q2 2022 Earnings Call Transcript
Motley Fool Transcribers
|
Nov 30, 2021
BNED earnings call for the period ending October 30, 2021.
View More Articles